Chapter 7

Tyrosine Kinase Inhibitor and Target Therapy

Brilli Lucia

Abstract

“Tyrosine kinase inhibitors” (TKI) are small molecules responsible for selectively inhibiting cellular pathways involved in cell proliferation or migration. These molecules have been developed as alternative therapy for refractory or minimal responsive cancers to standard treatments. In this chapter, TKI currently used for anaplastic thyroid cancer, medullary thyroid cancer and/or refractory differentiated thyroid cancer will be described.

Total Pages: 85-95 (11)

Purchase Chapter  Book Details